ArthroCare Corp
-
Big Returns Come from Small Cap Medical Technology
By Streetwise Reports - March 26, 2012 | Tickers: ARTC, BMY, MAKO, NUVA, SLTM
George S. Mack, The Life Sciences Report
Forget big medtech and find your growth plays in niche companies.
A decade ago medtech was in its heyday. Baby boomers were already feeling the discomforts of osteoarthritis and other age-related diseases, and they wanted to be active longer. Device and instrument developers could innovate and get products through the FDA and market them in the U.S. where dynamic pricing power would more »
-
Targeting Medtech Stocks
By Streetwise Reports - March 19, 2012 | Tickers: ARTC, CFN, COV, MDT, STJ
George S. Mack, The Life Sciences Report
I recently had an interesting conversation with BMO Capital Markets Managing Director Joanne Wuensch. She's a medical technology analyst who understands the forces creating demand as well as those that are depressing innovation in new technology. People have an interest in technology stocks because these innovative companies represent an opportunity for growth. That's been true since the invention of the wheel more » -
J.P. Morgan Healthcare Conference Schedule: Day One
By Brandy Betz - January 8, 2012 | Tickers: ARAY, ACOR, A, ALGN, AMRN, AMGN, AMLN, ARTC, BIIB, BMRN, BRKR, CFN, CTRX, CELG, CNC, COV, DNDN, XRAY, EW, ENDP, EPOC, ESRX, GHDX, GILD, HLS, HTWR, HMSY, HGSI, IDXX, IPXL, INCY, IRWD, MCK, MRX, MDT, MR, MOH, MYL, NVS, ONXX, PRX, PRGO, QSII, REGN, RMD, RIGL, SGEN, ST, SIAL, THC, MDCO, THOR, VRTX, VVUS, WAT, WMGI, ZLTQ
The 30th Annual J.P. Morgan Healthcare Conference kicks off with a full day of presentations from companies that range from global pharmaceutical leaders to small cap novel pharmaceutical developers and health technology manufacturers. The majority of the presentations will be available through live webcasts with archived replay offered later in the day.
I will be following (and covering) the novel therapeutic companies that have caught my eye. VIVUS (NASDAQ: VVUSmore »)